Journal honors Michael Postow, MD, as recipient of the 2013 Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award, supported by JCO.

摘要

Journal of Clinical Oncology (JCO) is pleased to bestow its 2013 Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award (YIA) on Michael Postow, MD, who is currently a fellow in medical oncology at Memorial Sloan-Kettering Cancer Center (New York, NY). The title of his research is "Combining Ipilimumab with Radiotherapy for Patients with Meta-static Melanoma." Created in 1984, the YIA provides research funding to young oncologists to support their transition from final years of training to faculty appointment and to encourage quality research in clinical oncology. The original idea for JCO to sponsor a YIA came from George Canellos, MD, during his 1993 to 1994 tenure as ASCO's president, as an opportunity for JCO to encourage researchers in the beginning of their careers. The Research Although treatment options for advanced melanoma have historically been limited, significant advances have recently been made. One such advance involves treatment with the immunomodulatory antibody ipilimumab, which enhances antitumor immunity and improves overall survival. Unfortunately, ipilimumab does not help every patient, and Dr Postow has focused his research efforts on investigating ways ipilimumab treatment could be improved.